GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » YoY EBITDA Growth

Abattis Bioceuticals (Abattis Bioceuticals) YoY EBITDA Growth : 98.94% (As of Sep. 2019)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Abattis Bioceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2019 was 98.94%.

Abattis Bioceuticals's EBITDA per Share for the three months ended in Sep. 2019 was $-0.00.


Abattis Bioceuticals YoY EBITDA Growth Historical Data

The historical data trend for Abattis Bioceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals YoY EBITDA Growth Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.35 71.43 -138.89 -304.65 97.13

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -452.94 90.91 100.00 90.00 98.94

Abattis Bioceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Abattis Bioceuticals's YoY EBITDA Growth for the fiscal year that ended in Sep. 2019 is calculated as:

YoY EBITDA Growth (A: Sep. 2019 )
=(EBITDA per Share (A: Sep. 2019 )-EBITDA per Share (A: Sep. 2018 ))/ | EBITDA per Share (A: Sep. 2018 ) |
=(-0.005--0.174)/ | -0.174 |
=97.13 %

Abattis Bioceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2019 is calculated as:

YoY EBITDA Growth (Q: Sep. 2019 )
=(EBITDA per Share (Q: Sep. 2019 )-EBITDA per Share (Q: Sep. 2018 )) / | EBITDA per Share (Q: Sep. 2018 )) |
=(-0.001--0.094)/ | -0.094 |
=98.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abattis Bioceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.